DNA-based Skin Care Products Market Size, Share & Trends Analysis Report, By Product (Creams, Serums); By Distribution Channel; By Region; Segment Forecasts, 2022 - 2030
- Published Date:Nov-2022
- Pages: 119
- Format: PDF
- Report ID: PM2794
- Base Year: 2021
- Historical Data: 2018-2020
Report Outlook
The global DNA-based skin care products market was valued at USD 6.02 billion in 2021 and is expected to grow at a CAGR of 6.33% during the forecast period.
The rising prevalence of acne, melanomas of the skin, and atopic dermatitis have grabbed the consumer’s attention to focus more on their skin wellness which acts as a driving factor for market growth. Moreover, growing advancements in science and recent developments by key market players will significantly contribute to the overall market growth.
Know more about this report: Request for sample pages
Moreover, the increasing lack of nutritional diet along with the growing eating disorders among the global population is projected to increase various ailments, including skin disorders, thereby propelling the overall market growth.
As per the American Society for Nutrition, an estimated 24 million people in America suffer from eating disorders. Also, the source stated that eating disorders grew from 3.5% between 2000-2006 to 7.8% between 2013-2018. The growing number of eating disorders is projected to lead to several health problems, especially skin and hair ailments, thereby increasing the demand and market growth of DNA-based skin care products across the globe.
According to the data published by World health organization in 2018, skin disease is predicted to be the most common of all human health afflictions and affects almost 900 million people worldwide. The rising prevalence of skin diseases has created a huge demand for DNA-based skin care products.
Know more about this report: Request for sample pages
Industry Dynamics
Growth Drivers
The rising prevalence of skin conditions such as acne and melanomas of skin are projected to drive the demand for DNA-based skin care products. Acne is one of the most common skin conditions in every corner of the globe and causes pimples on the forehead, face, chest, upper back, and shoulders. It is one of the most common skin conditions which affects teenagers and people of all ages, and that is why it is expected to drive the overall market growth during the forecast period. The rising prevalence of acne and the easy availability of these advanced skin care products are the major driving factor for the market growth.
Another factor contributing to the market growth is the rising concerns about skin health. The market is expected to surge in the coming years due to the growing awareness about skin health. It has been observed that with time modern consumers are becoming aware that in order to maintain good skin health, it is necessary to take care of the skin by consuming edible nutrients and by applying topical applications. Also, it has often been noticed that customers complain about cosmetics causing rashes or allergies to a particular skin type, while on the other hand, it may not be the case for some other skin types.
Hence, in order to avoid such issues, consumers are moving towards DNA-based skin type products as they are applied only after the gene testing of the consumer. The common ingredients found in various DNA-based skin products have associated beauty benefits which include vitamin A, which aid in reducing wrinkles and brown spots and smoothens roughness; vitamin C, which helps in collagen production B3 for boosting hydration; B6 for skin improvement and also help in the treatment of acne; and B12 for the reduction of redness, skin dryness, and acne blemishes.
Report Segmentation
The market is primarily segmented based on product, distribution channel, and region.
|
By Product |
By Distribution Channel |
By Region |
|
|
|
Know more about this report: Request for sample pages
Creams segment is expected to witness fastest growth in 2022
DNA-based creams are anticipated to dominate the overall segment growth during the forecast period owing to intense hydrating, cosmetic benefits, and high moisturizing properties. DNA-based creams target the aging process by penetrating deep below the skin’s surface; they are highly used by women in their anti-aging skincare routine. This cream contains a special enzyme called telomerase which protects the cells from damage and premature aging.
DNA-based serums are likely to grow in the next five years due to their specialized properties, which help in reducing wrinkles and skin redness, improving texture, strengthening skin, and protecting the skin from harmful UV rays. Although, lack of awareness among the old population regarding the usage of serum is the major reason for their slow growth.
Offline distribution channel is expected to dominate the overall segment growth
The offline distribution channel holds the largest market share during the forecast period. The main reason behind offline sales is the rising concerns among consumers for genetic mapping and testing. Consumers prefer to get their genes tested at health and wellness clinics instead of using testing kits at home itself, as they believe tests performed by healthcare professionals and doctors are more accurate, which can help them in opting for their beauty routines and grooming more perfectly.
On the other hand, online distribution channels will likely grow in the coming years as well due to the rising awareness among consumers about the use of testing kits, promotional activities and advertisements by small and large players and the increasing popularity of e-commerce platforms like Amazon, Myntra, Marie Claire, Skin Store and among others.
The demand in North America is expected to witness significant growth
The rising number of dermatology practices in North America and the growing popularity of skin and beauty products in countries like the US and Canada are the factors that are contributing to the market growth in the region.
As per the Harvard Medical School, there were 184 practice acquisitions by 17 private equity (PE) backed dermatology management groups (DMG) for the period between May 1, 2012, and May 22, 2018. Also, practice acquisitions by DMGs increased from 5 in 2012 to 59 in 2017. The study concluded that there is a rising trend of private equity firms’ stake in the number of dermatology practices in the United States.
Furthermore, the growing investments and acquisitions in dermatological practices are another major contributor to the anticipated growth of dermatological and DNA-based skin products in the region.
Moreover, Asia-Pacific is anticipated to grow at the fastest CAGR due to the rising demand for DNA-based beauty products in countries like China, India, and South Korea. Manufacturers in the market are planning to enter the Asian markets and launch their products which are projected to drive the overall market growth in the region.
Competitive Insight
Some major players operating in the global market include EpigenCare, Jinomz, Caligenix, SkinGenie, dnaskin, ALLEL, Targeted DNA, Imagine Labs, Evergreen Health, SkinDNA, ANAKE, DNA Skin Institute, Genetic Beauty, Skinshift, and Natural Organic Body.
Recent Developments
In Jun 2022, Gene skin, a DNA testing company, launched a new personalized skincare treatment test. The test is helpful in scientifically researching genes that help in collagen production and an individual’s ability to utilize vitamins and minerals.
In Oct 2021, SkinDNA introduced a biomimetic skincare range BIOMIMIC after a decade of genetic and aging research. The new skincare range is launched to address the five main skin aging pathways to help consumers worldwide preserve their youthful-looking skin.
In Dec 2020, EpigenCare Inc., a biotechnology company which has specialized in consumer epigenetics, launched SKINTELLI personalized skincare test. This product is a direct-to-consumer DNA test that is offered for $99.
DNA-based Skin Care Products Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2022 |
USD 6.33 billion |
|
Revenue forecast in 2030 |
USD 10.35 billion |
|
CAGR |
6.33% from 2022 - 2030 |
|
Base year |
2021 |
|
Historical data |
2018 - 2020 |
|
Forecast period |
2022 - 2030 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2022 to 2030 |
|
Segments Covered |
By Product, By Distribution Channel, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
|
Key Companies |
EpigenCare, Jinomz, Caligenix, SkinGenie, dnaskin, ALLÉL, Targeted DNA, Imagine Labs, Evergreen Health Solutions Ltd., and SkinDNA, ANAKE, DNA Skin Institute, among others. |
